Burillon, C., Chiambaretta, F., & Pisella, P. (2018). Efficacy and safety of glycyrrhizin 2.5% eye drops in the treatment of moderate dry eye disease: Results from a prospective, open-label pilot study. Clinical Ophthalmology, 12, 2629. https://doi.org/10.2147/OPTH.S186074
Chicago Style (17th ed.) CitationBurillon, Carole, Frederic Chiambaretta, and Pierre-Jean Pisella. "Efficacy and Safety of Glycyrrhizin 2.5% Eye Drops in the Treatment of Moderate Dry Eye Disease: Results from a Prospective, Open-label Pilot Study." Clinical Ophthalmology 12 (2018): 2629. https://doi.org/10.2147/OPTH.S186074.
MLA (9th ed.) CitationBurillon, Carole, et al. "Efficacy and Safety of Glycyrrhizin 2.5% Eye Drops in the Treatment of Moderate Dry Eye Disease: Results from a Prospective, Open-label Pilot Study." Clinical Ophthalmology, vol. 12, 2018, p. 2629, https://doi.org/10.2147/OPTH.S186074.